ghk-cu.hu / Articles / Checklist

12 Questions to Ask Before Trusting a GHK-Cu Study

A practical framework for non-specialists to separate high-certainty evidence from marketing claims in peptide research.

By Zoltán Varga2026-11-055 min read

Design and Population Validity

Start by identifying the study type. Randomized controlled trials (RCTs) provide the highest initial certainty. Observational studies or case reports start at a lower certainty level. Check if the population matches your needs. A study on healthy young adults does not apply to elderly patients with chronic wounds. Look for sample size details. Small groups often produce wide confidence intervals. This creates imprecision in the results. A study with only two or three participants cannot establish general rules. Check for control groups. Without a control group, you cannot distinguish the effect of the peptide from natural healing or placebo responses. Verify if the study was registered beforehand. Pre-registration prevents researchers from changing their goals after seeing the data.

• Confirm the study is a randomized controlled trial or a systematic review of such trials.
• Ensure the participant demographics match the intended use case.
• Check for a minimum sample size that allows statistical power.
• Verify the presence of a control group receiving a placebo or standard care.

Route of Administration and Formulation

The method of delivery changes the outcome entirely. Topical application affects skin surface layers. Intravenous or subcutaneous injection reaches systemic circulation. A study using injections does not prove topical efficacy. Many peptides degrade quickly in the digestive tract. Oral administration requires specific formulation to survive stomach acid. Check if the study specifies the salt form. Copper peptides exist as acetates or other salts. Stability varies by formulation. Poor stability leads to inactive compounds. Verify the vehicle used in topical studies. Creams, gels, and serums alter absorption rates. A result from a lab solution does not transfer to a cosmetic cream without proof. Note that regulatory bodies like the FDA have flagged certain bulk substances for significant safety risks when compounded without standardization. Lack of standardization makes cross-study comparison impossible.

• Match the route of administration to your intended use.
• Confirm the specific chemical salt and formulation stability.
• Check if the vehicle (cream vs. serum) was tested for absorption.
• Be wary of studies mixing routes without separate data analysis.

Endpoints and Comparators

Define what the study measured. Biological markers differ from clinical outcomes. A change in collagen gene expression does not guarantee visible skin improvement. Look for objective endpoints. Imaging, biopsies, or blood tests provide harder data than self-reported surveys. Check the comparator. Did the study compare the peptide to nothing, a placebo, or an existing treatment? Comparing to nothing inflates perceived effects. Assess the duration. Short-term studies miss long-term safety issues or delayed benefits. Some effects require weeks to manifest. Others fade quickly. Verify if the study measured safety alongside efficacy. Adverse events like allergic reactions or unexpected pigmentation changes matter. The FDA has noted cases of hyperpigmentation linked to peptide use in specific contexts. Ensure the endpoint aligns with the claim. A study on gut healing does not support a claim for anti-aging skin benefits.

• Prioritize objective clinical endpoints over surrogate biological markers.
• Ensure the control group received a placebo or standard treatment.
• Check that the study duration covers the expected time for results.
• Verify that safety data was collected with equal rigor to efficacy data.

Funding and Independence

Identify who paid for the research. Industry-funded studies often show favorable outcomes compared to independent ones. Check for conflict of interest disclosures. Authors working for peptide manufacturers have a bias. Look for third-party verification. Independent labs repeating the work increase confidence. Check if the study was peer-reviewed. Peer review filters out obvious methodological flaws. It is not a guarantee of truth, but it is a baseline filter. Be skeptical of preprints without peer review. These are drafts that have not been vetted. Check if the data is publicly available. Transparency allows others to audit the calculations. Hidden data suggests potential manipulation. Note that some regulatory reviews have highlighted risks when compounds are sourced from vendors without verified manufacturing standards.

• Look for funding sources unrelated to the product manufacturer.
• Check for explicit conflict of interest statements from all authors.
• Verify the study underwent peer review in a reputable journal.
• Seek independent replication of the findings by other research teams.

Replication and Review Status

One study is rarely enough. Science requires replication. Check if other teams have repeated the experiment. Consistent results across different labs build high certainty. Inconsistent results suggest the finding is fragile. Look for systematic reviews. These aggregate all available studies to find the true effect. They use frameworks like GRADE to assign certainty levels. A systematic review might label evidence as 'very low' if only small, flawed studies exist. Check the date of the research. Older studies may use outdated methods. Newer studies benefit from better technology. However, do not ignore older foundational work if it has been replicated. Search for negative results. Publication bias hides studies that found no effect. If only positive papers exist, the true success rate may be lower. Regulatory bodies have noted that many human trials for peptides remain unpublished or exist only as abstracts.

• Require at least two independent studies showing similar results.
• Consult systematic reviews that grade the overall certainty of evidence.
• Check for the existence of unpublished or negative studies.
• Verify if the findings have been replicated in different populations.

Scoring Your Answers

Assign a certainty level based on your answers. Use the GRADE framework logic. Start with high certainty for randomized trials. Downgrade for risk of bias, inconsistency, indirectness, imprecision, or publication bias. Upgrade only if there is a large effect size or dose-response gradient. Most peptide studies currently fall into moderate or low certainty categories. Very few meet the criteria for high certainty. A single flaw in design can drop the certainty level significantly. Do not rely on anecdotal reports or forum posts. These lack controls and blinding. They serve as hypotheses, not evidence. Treat claims with 'very low' certainty as experimental. Wait for further research before making health decisions. This approach protects against false hope and financial loss.

• Downgrade certainty for any major methodological flaw.
• Classify single small studies as low or very low certainty.
• Reserve high certainty for multiple replicated, blinded trials.
• Ignore claims that cannot be traced to a primary research paper.

AI-assisted: drafted with a language model from the author's research notes, then edited and checked before publication. Author: Zoltán Varga, AI visibility researcher and AI ecosystem architect, Budapest.